HONG KONG, Feb. 3, 2026 /PRNewswire/ — On January 15, Qingdao Guoen Technology Co., Ltd. (SHE: 002768) announced that it has successfully passed the hearing of the Hong Kong Stock Exchange (HKEX) Main Board, marking a significant milestone in its pursuit of a dual listing on both the Shenzhen and Hong Kong stock exchanges. The company’s H-share initial public offering (IPO) will be exclusively sponsored by China Merchants Securities International.

According to the updated prospectus and official announcement dated February 3, Guoen Technology has finalized the issue price of its H-shares at HK$36.00 per share, excluding relevant fees. A total of 30 million shares will be offered globally—3 million for the Hong Kong public offering and 27 million for international placement, with an over-allotment (greenshoe) option available. The Hong Kong public offering period ran from January 27 to January 30. Trading of the H-shares is scheduled to commence on February 4, 2026, on the HKEX Main Board.

This IPO is expected to raise capital primarily for the development of domestic and overseas manufacturing bases, as well as to supplement working capital—supporting the company’s long-term goal of building a cross-market, globally integrated supply platform.

Founded in Qingdao, Guoen Technology is a leading player in the advanced polymer materials sector. The company operates a vertically integrated platform covering the entire value chain of high-performance plastics—from raw material polymerization to modification, compounding, and the manufacturing of end-use products. Its product portfolio spans modified plastics, composite materials, and biodegradable polymers, with strong applications in sectors such as new energy vehicles, smart manufacturing, consumer electronics, and healthcare.

Notably, Guoen is accelerating investment into strategic materials such as PEEK (polyether ether ketone), a high-performance engineering thermoplastic widely used in aerospace, medical devices, and robotics. The company has announced plans to establish 1,000-ton annual PEEK production capacity, positioning itself at the forefront of domestic innovation and import substitution in this field.

This is a critical step for Guoen Technology to deepen capital market access, enhance international brand recognition, and advance its ambition to become a global materials technology platform.

Company delivers more than 100 kilometers to one of its customers and accelerates toward gigawatt-hour scale manufacturing

SANTA CLARA, Calif., Feb. 3, 2026 /PRNewswire/ — Elevated Materials today announced major milestones as it celebrates its one-year anniversary, highlighting rapid growth in production, customer adoption, and organizational scale. Elevated Materials was carved out of Applied Materials on February 1, 2025, with an investment from the TPG Rise Climate Fund.

The company closed 2025 with record output of ultra-thin lithium metal films, shipping product to more than 30 customers worldwide. Notably, Elevated Materials delivered more than 100 kilometers of lithium film to a single customer, underscoring strong market demand for high-quality, scalable lithium metal solutions.

“The industry has long been seeking a reliable source of high-quality, ultra-thin lithium films to improve battery performance,” said Jim Cushing, CEO of Elevated Materials. “We are filling that gap with our ultra-thin, smooth, and low-defect ELi™ films. Demand has been particularly strong for lithium metal anodes, where ELi significantly improves both safety and performance.”

Elevated Materials’ proprietary roll-to-roll vacuum deposition platforms produce ELi, the industry’s highest-quality ultra-thin lithium metal films. These films enable next-generation anode architectures across electric vehicles, consumer electronics, aviation, and grid-scale energy storage.

The company’s production momentum reflects the growing urgency among battery manufacturers to secure reliable supplies of ultra-thin lithium metal anodes as advanced cell designs move closer to commercial deployment.

Looking ahead, Elevated Materials noted that 2026 will be focused on scaling production to meet increasing customer demand.

“As we move into 2026, Elevated Materials will continue ramping to true gigawatt-hour scale manufacturing,” Cushing added. “With accelerating customer demand, we are tripling production capacity to support the commercial battery programs of our key customers.”

Elevated Materials’ successful first year and rapid scale-up reinforce its position as a critical supplier for next-generation battery developers seeking consistent, scalable lithium metal solutions.

About Elevated Materials
Elevated Materials is a TPG Rise Climate portfolio company carved out of Applied Materials and focused on scaling breakthrough battery technologies to accelerate global decarbonization and electrification. The company draws on decades of expertise in semiconductors and roll-to-roll vacuum deposition to deliver the industry’s widest and highest-quality ultra-thin lithium films. Elevated’s films boost energy density, extend battery life, and enable significantly faster charging across lithium-ion battery applications and anode chemistries.

HONG KONG, Feb. 3, 2026 /PRNewswire/ — CIMG Inc. (“CIMG” or the “Company”) (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners’ sales growth and commercial value, today announced that its subsidiary, Beijing Xinmiao Shidai Technology Development Co., Ltd. has entered into five sales contracts for computing power hardware equipment with multiple companies, including Guangzhou Liangjingjing Technology Co., Ltd., Tianjin Herunsheng Technology Development Co., Ltd., Tianjin Weixinda Technology Co., Ltd., and Tianjin Lanhai Interaction Technology Co., Ltd., which contracts were executed between December 2025 and January 2026. The total contract value, including taxes, amounts to approximately $2 million.

The products covered by these contracts include two main categories, computing servers and power electronic components, and are intended for customers such as cloud service providers and industrial enterprises. These contracts reflect the Company’s continued expansion in the core hardware segment of the computing power infrastructure industry and are expected to contribute to the Company’s financial performance and operating results in 2026.

Alice Wang, Chairperson of the Board and Chief Executive Officer of CIMG Inc., stated, “With the industrial deployment of large-scale models and the deepening of the China ‘East Data West Computing; strategy, computing power has evolved from a basic resource into a strategic asset comparable to semiconductors and energy. Our continued focus on the artificial intelligence computing power sector is intended to support long-term customer resources and strengthen our competitive positioning.”

“Currently, the Company is focused on developing ‘scenario-based computing power solutions.’ To address the varying technical needs and budget constraints of different clients, the Company provides end-to-end services, including hardware configuration, equipment installation and debugging, optimization and after-sales support, aimed at addressing compatibility issues in traditional computing power procurement. The Company expects to continue expanding its business in the computing power facility services sector, leveraging innovative business models to capture opportunities arising from the global AI industry development,” added Alice Wang.

About CIMG

CIMG is a business group specializing in digital health and sales development, with a cryptocurrency-focused strategy. The Company leverages AI and cryptocurrencies (such as Bitcoin and stablecoins) to drive business growth, helping clients maximize user growth and enhance brand management value. The Company’s current client portfolio includes brands such as Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango.

Forward-Looking Statements

This press release contains information about the Company’s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks related to the execution, timing, and realization of supply and sales contracts, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary for its operations, and its ability to protect its intellectual property. The Company encourages you to review other factors that may affect its future results in its Annual Reports, Quarterly Reports, registration statements, and other filings with the Securities and Exchange Commission.

QINGDAO, China, Feb. 3, 2026 /PRNewswire/ — Akso Health Group (NASDAQ: AHG) (“Akso Health” or the “Company”) today announced the launch of the an exploratory patient support program and a strategic cooperation with Nanning Duoling Research Institute. Adopting an integrated model of “Traditional Chinese Medicine (TCM) practice + modern medical technology”, certain medical resources will be coordinated and integrated to provide free in-hospital treatment plans for up to 10,000 eligible patients within participating medical institutions. The patient support program directly addresses the urgent needs of cancer patients and reconstructs the standards of medical accessibility through “global resource integration + zero-cost access”.

Akso Health plans to open its global medical network, connecting the radiation oncology centers under its planning and construction withtargeted drugs andremote consultation teams. Pursuant to a strategic cooperation framework agreement, Nanning Duoling will provide its exclusive cancer diagnosis and treatment technologies, reagent and consumable supply system, professional laboratory testing capabilities, and an exclusive team composed of experts in the field of cancer diagnosis and treatment.  The two parties will work together to build a closed-loop model of “global resource connection + local technology landing + full-cycle patient service”, and the core breakthrough of this model is “zero-cost full-chain coverage”, which directly addresses the core pain points of high medical costs, difficulty in accessing medical care, and uneven treatment effects faced by more than 20 million new cancer patients worldwide and 4.06 million new annual cases in China.

This program is an important initiative for the Company to continuously explore how to improve the actual accessibility of specific medical support resources within the compliant medical system. It aims to explore a potential framework for coordinating and integrating third-party medical resources through licensed and compliant medical institutions to help patients obtain specific medical services. Any services that may be provided under the program will be fully offered by independent medical institutions and licensed medical professionals, rather than directly by the Company. Specific arrangements, if any, must meet conditions such as patient eligibility, institutional qualifications, applicable regulatory requirements, and funding accessibility.

The Company believes that the launch of this exploratory global patient support initiative may allow for further assessment of scalability and feasibility, subject to ongoing review.

Akso Health emphasized that the long-term value of healthcare innovation lies not only in research and development, but also in the ability to responsibly evaluate implementation models within real-world medical systems. Through the integration of institutional experience, research collaboration, and system-level coordination, the Company continues to explore ways to support sustainable and compliant healthcare accessibility.

Yilin (Linda) Wang, Chief Executive Officer of Akso Health Group, stated,
“We believe it is important to responsibly explore ways to support broader access to healthcare resources, while fully respecting regulatory boundaries and the essential role of licensed medical professionals. This initiative represents an early-stage effort, and we intend to proceed cautiously and deliberately.”

The initiative is designed to assess potential approaches to enhancing healthcare accessibility through structured coordination and support mechanisms, while maintaining a clear separation between the Company’s corporate activities and the delivery of regulated medical services. Participation, if available, would be offered on a limited and phased basis and does not involve any commercial promotion of medical products or therapies.

Patients or family members interested in participating in the free treatment support program may register or make inquiries via the following email address: ir@ahgtop.com. All applications will be collected centrally, and eligible applicants will be contacted in due course.

About Akso Health Group

Akso Health Group (NASDAQ: AHG), formerly known as Xiaobai Maimai Inc., upon exploration of e-commerce platforms, the Company started exploring the healthcare equipment and product trading and related healthcare services business. Currently, the Company specializes in the sales of medical devices in China and in the United States and also conducts certain radiotherapy oncology center-related operations in the United States. In March 2024, the Company indirectly acquired equity interests in Tianjin Deyihui Internet Hospital and Tianjin Deyihui Clinic Co., Ltd., which provide online medical consultations for initial diagnosis, follow-up consultations, and management of chronic diseases.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potential,” “continue,” “ongoing,” “targets,” “guidance” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements that involve factors, risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors and risks include, but not limited to the following: risks related to our ability to obtain equipment, technology, license and talents at satisfactory terms to grow the medical equipment business and/or to start the planned healthcare business, if at all; risks related to the Company’s ability to adapt and make the necessary adjustments to compete and operate effectively; risks related to decisions or changes in governmental policies in the healthcare segment; risks related to increased competition and the development of new competing services; the risk that we may be unable to develop or achieve commercial success for our medical and healthcare services in a timely manner, or at all; risks related to regulatory requirements or enforcement in relevant jurisdiction and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to successfully integrate and derive benefits from any technologies that we license or acquire; risks related to our projections about our business, results of operations and financial condition; risks related to the potential market opportunity for our products and services; and risks related to uncertainties in regulatory oversight of healthcare-related services, limitations on the promotion or commercialization of unapproved medical products; risks that any evaluated service models may not progress beyond exploratory stages; risks on healthcare service arrangements, limitations on the promotion or delivery of medical-related services, uncertainties regarding third-party medical providers, and the risk that contemplated collaborations may not progress beyond preliminary or framework stages. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this announcement is current as of the date of this announcement, and the Company does not undertake any obligation to update such information, except as required under applicable law.

For more information, please visit http://www.ahgtop.com/en/index.html 

For investor inquiries, please contact:

Akso Health Group
Investor Relations
Email: ir@ahgtop.com 
Website: www.ahgtop.com

Didcom is recognized for driving customer acquisition and operational transformation through engineering excellence and intelligent mobility solutions.

SAN ANTONIO, Feb. 3, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Didcom has been awarded the 2025 Mexican Customer Value Leadership Recognition in the Intelligent Mobility & Connected Truck Telematics sector for its outstanding achievements in engineering innovation, ecosystem partnerships, and customer-focused operational transformation. This recognition highlights Didcom’s consistent leadership in delivering cost-efficient, reliable, and scalable telematics solutions that build lasting operational trust in a rapidly evolving mobility landscape.

Guided by a long-term growth strategy centered on AI-powered analytics, Edge Intelligence, and real-time data capabilities, Didcom has shown its ability to adapt and lead in an increasingly intelligent and connected mobility environment. The company’s strategic agility and sustained investment in proprietary engineering, modular sensor-to-cloud architecture, and OEM-aligned integration have enabled it to scale effectively across Mexico while strengthening its presence in broader North American and international markets. “Didcom’s customer acquisition model thrives on long-standing partnerships, strong engineering alignment with OEMs, and the ability to deploy scalable solutions that adapt to evolving fleet needs,” states Benson Augustine, Program Manager for Aftermarket & Digital Retail, Mobility, at Frost & Sullivan.

Innovation is central to Didcom’s approach. Its comprehensive platform integrates OEM-embedded connectivity, aftermarket versatility, and engineering-driven integration within interoperable ecosystems that support traditional, hybrid, and electric fleets. By consolidating real-time operational data—including vehicle health, energy usage, safety signals, and driver behavior—into a unified intelligence-ready environment, Didcom enables fleets to move from manual oversight to predictive, automated, and AI-assisted operations. This approach improves efficiency, enhances safety outcomes, and ensures continuity and reliability across diverse operating conditions.

Didcom’s unwavering commitment to customer experience further strengthens its position as a customer value leader. By prioritizing reliability, continuity, and operational trust, the company delivers a strong ownership experience supported by localized engineering expertise and responsive partner ecosystems. Its modular architecture and cost-efficient pricing strategy enable fleets and manufacturers to achieve measurable economic impact through fuel and energy optimization, predictive maintenance, and intelligent operational decision-making.

“This Customer Value Leadership recognition by Frost & Sullivan confirms what has guided Didcom since day one: engineering must translate into real operational value for our customers. We don’t build technology for the sake of innovation—we design solutions that fleets can trust, scale, and operate with confidence. This recognition reinforces our responsibility to continuously strengthen reliability, execution, and intelligent mobility built from the ground up,” said Eng. Yojanan Cornejo Chait, Didcom CEO & Founder.

Frost & Sullivan commends Didcom for setting a high standard in competitive strategy, execution, and market responsiveness. The company’s vision, engineering excellence, and ecosystem-led innovation are shaping the future of intelligent mobility and connected truck telematics while delivering tangible results at scale.

Each year, Frost & Sullivan presents the Customer Value Leadership Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in customer satisfaction, operational performance, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact
Camila Tinajero
camila.tinajero@frost.com

About Didcom

Didcom is a Mexican company specializing in applied engineering, smart hardware, embedded systems, telematics, and advanced solutions for mobility and fleet operations. With over 17 years of experience, Didcom drives operational efficiency through high-impact technologies focused on safety, productivity, and data-driven decision-making. Visit Didcom at didcom.com.mx

Contact
Fernando García
Marketing Manager
fernando.garcia@didcom.com.mx